|
JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300NFZYYFSCD52W53 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 29 February 2020 |
|
|
GlaxoSmithKline |
4.8% |
|
JPMorgan Smaller Companies Investment Trust |
4.5% |
|
AstraZeneca |
4.3% |
|
Royal Dutch Shell |
4.3% |
|
British American Tobacco |
3.5% |
|
HSBC |
2.7% |
|
Legal & General |
2.3% |
|
RELX |
2.3% |
|
Lloyds Banking |
2.1% |
|
Prudential |
2.1% |
|
Total |
32.7% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Faith Pengelly 0044 207 742 8627 - Company Secretary |
|
|
Date: 11 March 2020 |
|
|
|
|